( April 30, 2026, 8:46 AM EDT) -- WASHINGTON, D.C. — The U.S. Supreme Court will consider at its May 14 conference a petition for review of an appeal regarding a final judgment of $193 million for a qui tam relator who sued Eli Lilly & Co. for reporting falsely deflated drug prices to the government in order to profit off of drug rebate programs, according to an April 28 docket entry....